Physician profile
Gaia Hess
NPI 1861061939
$891.93
in general payments reported to CMS, 2019-2025
10 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $434 · 2023: $197 · 2024: $25.46 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $408 · Entertainment: $49.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $408.44 |
| Entertainment | $49.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $287.29 | 2022-2025 | Wavelight Refractive Suite, Dailies Total1, Precision7 |
| Tarsus Pharmaceuticals, INC. | $147.08 | 2025 | Xdemvy |
| Oyster Point Pharma, INC. | $98.56 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $95.61 | 2022 | |
| Coopervision INC. | $91.04 | 2022-2023 | Paragon Crt |
| Allergan, INC. | $77.95 | 2022 | |
| Lombart Brothers, INC. | $41.32 | 2023-2024 | Opd-III |
| Optos, INC. | $38.52 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Abbvie INC. | $14.56 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaia Hess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.